Double-blind, randomized, placebo-controlled, First in Human study of Etc-206 in Healthy Volunteers.

Trial Profile

Double-blind, randomized, placebo-controlled, First in Human study of Etc-206 in Healthy Volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Mar 2018

At a glance

  • Drugs ETC-1907206 (Primary)
  • Indications Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
  • Focus Adverse reactions; First in man; Pharmacodynamics; Pharmacokinetics
  • Most Recent Events

    • 27 Mar 2018 New trial record
    • 24 Mar 2018 Results presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top